Pulse Infoframe
Highly Engaged Employees
Healthcare Software · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
235 N Centre Rd Ste 101, London, Ontario...Phone Number
(226) 271-4194Website
www.pulseinfoframe.comRevenue
<$5 MillionIndustry
About Pulse Infoframe
Pulse Infoframe Org Chart
Is Pulse Infoframe your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Pulse Infoframe recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Pulse Infoframe
Funding: Get notified immidiatlly once Pulse Infoframe has new funding data
Click to see if Pulse Infoframe had a recent Job posting/layoffs
Pulse Infoframe, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Pulse Infoframe has recently received funding, and reach out quickly before it becomes old news!
Check out if Pulse Infoframe is spiking on competitors!
Product Launch: Get notified when Pulse Infoframe launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Pulse Infoframe
Compare insights from companies similar to Pulse Infoframe, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pulse Infoframe is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Pulse Infoframe is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Pulse Infoframe.
Pulse Infoframe Tech Stack
A closer look at the technologies used by Pulse Infoframe
Most Recent Scoops
Pulse Infoframe News & Media
Endo Announces First Patient Enrolled in Registry of Dupuytren's Contracture
DUBLIN, June 26, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that the first patient has been enrolled in GRASP-DC (Generating Real-world Ambispective data to Study Participant Treatment outcomes for Dupuytren's Contracture), a non-interventional registry of up...Pulse Infoframe Appoints New Chief Commercial Officer
Expert in research design and real-world evidence, Gordon Cummins, will create significant value for clients in new role LONDON, ON, Nov. 1, 2022 /PRNewswire/ -- Pulse Infoframe, an industry leader in real-world evidence (RWE), announced today that Gordon Cummins has joined the company as...Timothy Syndrome Alliance & Pulse Infoframe collaborate on registry for rare CACNA1C-related disorders
Research to focus on gene at "heart" of Timothy Syndrome LONDON, ON, March 24, 2022 /PRNewswire/ -- Timothy Syndrome Alliance (TSA) is creating a patient registry for the CACNA1C gene, which encodes the alpha-1-subunit of a voltage-dependent L-type calcium channel highly expressed in the...The Myrovlytis Trust Leverages Pulse Infoframe's Platform to Study Birt-Hogg-Dubé Syndrome
LONDON, ON, Feb. 17, 2022 /PRNewswire/ -- The Myrovlytis Trust is creating a patient registry for Birt-Hogg-Dubé Syndrome (BHD) to better understand the epidemiology of the disease, its prevalence, and the disease trajectory, to improve the quality of life for this community, and to...
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pulse Infoframe
Pulse Infoframe is a global healthcare company that has developed a leading evidence-generating platform to accelerate research in oncology, rare diseases, and chronic conditions. The company collaborates with biopharmaceutical firms, research institutions, and patient advocacy groups to collect and share high-quality data, enhancing drug developme... Read More